Biodesix (BDSX) Notes Payables (2019 - 2025)
Biodesix's Notes Payables history spans 7 years, with the latest figure at $6000.0 for Q4 2025.
- For Q4 2025, Notes Payables fell 71.43% year-over-year to $6000.0; the TTM value through Dec 2025 reached $6000.0, down 71.43%, while the annual FY2025 figure was $6000.0, 71.43% down from the prior year.
- Notes Payables reached $6000.0 in Q4 2025 per BDSX's latest filing, down from $11000.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $14.3 million in Q3 2022 to a low of $6000.0 in Q4 2025.
- Average Notes Payables over 5 years is $1.6 million, with a median of $47000.0 recorded in 2022.
- Peak YoY movement for Notes Payables: crashed 99.92% in 2021, then skyrocketed 71570.0% in 2022.
- A 5-year view of Notes Payables shows it stood at $19000.0 in 2021, then soared by 157.89% to $49000.0 in 2022, then grew by 4.08% to $51000.0 in 2023, then crashed by 58.82% to $21000.0 in 2024, then tumbled by 71.43% to $6000.0 in 2025.
- Per Business Quant, the three most recent readings for BDSX's Notes Payables are $6000.0 (Q4 2025), $11000.0 (Q3 2025), and $16000.0 (Q2 2025).